Mostly Cloudy 32°
Tag:

Sascha Roth

News
Every Cancer Patient In Remission After Miraculous Memorial Sloan Kettering Drug Trial Every Cancer Patient In Remission After Miraculous Memorial Sloan Kettering Drug Trial
Every Cancer Patient In Remission After Miraculous Memorial Sloan Kettering Drug Trial More than 15 rectal cancer patients who participated in a drug trial at Memorial Sloan Kettering Cancer Center are in remission. The first patient to try the drug was Washington DC's Sascha Roth, who got the good news on a Friday evening just four weeks before she was scheduled to undergo weeks of radiation therapy. More than a dozen others would soon receive the good news. The MSK clinical trial was investigating if immunotherapy alone could beat rectal cancer that had not spread to other tissues, in a subset of patients whose tumor contained a specific genetic mutation, the hospital sai…

SHARE

by Cecilia Levine